BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33389862)

  • 1. Microbiome Conundrum in Colon Cancer: Development, Progression, and Therapeutics.
    Malla RR
    Crit Rev Oncog; 2020; 25(2):129-139. PubMed ID: 33389862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Microbiome in Carcinogenesis Process and Epigenetic Regulation of Colorectal Cancer.
    Farhana L; Banerjee HN; Verma M; Majumdar APN
    Methods Mol Biol; 2018; 1856():35-55. PubMed ID: 30178245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model.
    Fuller AK; Bice BD; Venancio AR; Crowley OM; Staab AM; Georges SJ; Hidalgo JR; Warncke AV; Angus-Hill ML
    J Vis Exp; 2018 Feb; (132):. PubMed ID: 29553541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotic strain Lactobacillus plantarum YYC-3 prevents colon cancer in mice by regulating the tumour microenvironment.
    Yue Y; Ye K; Lu J; Wang X; Zhang S; Liu L; Yang B; Nassar K; Xu X; Pang X; Lv J
    Biomed Pharmacother; 2020 Jul; 127():110159. PubMed ID: 32353824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal Microbiota and Colon Cancer.
    Hold GL
    Dig Dis; 2016; 34(3):244-50. PubMed ID: 27028619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota.
    Fidelle M; Yonekura S; Picard M; Cogdill A; Hollebecque A; Roberti MP; Zitvogel L
    Front Immunol; 2020; 11():600886. PubMed ID: 33381121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of the Microbiome in the Etiopathogenesis of Colon Cancer.
    El Tekle G; Andreeva N; Garrett WS
    Annu Rev Physiol; 2024 Feb; 86():453-478. PubMed ID: 38345904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Carcinogenesis and Gut Microbiota].
    Shiotani A; Fukushima S; Matsumoto H
    Gan To Kagaku Ryoho; 2019 Feb; 46(2):199-204. PubMed ID: 30914517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiome in Colonic Carcinogenesis.
    Sun J; Xia Y
    Compr Physiol; 2023 Jun; 13(3):4685-4708. PubMed ID: 37358517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of Colorectal Cancer by Anthocyanidins and Mitigation of Metabolic Shifts Induced by Dysbiosis of the Gut Microbiome.
    Mudd AM; Gu T; Munagala R; Jeyabalan J; Egilmez NK; Gupta RC
    Cancer Prev Res (Phila); 2020 Jan; 13(1):41-52. PubMed ID: 31796466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of intestinal microbiome in American ginseng-mediated colon cancer prevention in high fat diet-fed AOM/DSS mice [corrected].
    Wang CZ; Huang WH; Zhang CF; Wan JY; Wang Y; Yu C; Williams S; He TC; Du W; Musch MW; Chang EB; Yuan CS
    Clin Transl Oncol; 2018 Mar; 20(3):302-312. PubMed ID: 28808878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbial metabolism and colon cancer: can manipulations of the microbiota be useful in the management of gastrointestinal health?
    Belcheva A; Irrazabal T; Martin A
    Bioessays; 2015 Apr; 37(4):403-12. PubMed ID: 25601287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet-Derived Phytochemicals Targeting Colon Cancer Stem Cells and Microbiota in Colorectal Cancer.
    Ganesan K; Jayachandran M; Xu B
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32492917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The germ-organ theory of non-communicable diseases.
    Byndloss MX; Bäumler AJ
    Nat Rev Microbiol; 2018 Feb; 16(2):103-110. PubMed ID: 29307890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiota in Tumor Microenvironment: A Critical Regulator in Cancer Initiation and Development as Potential Targets for Chinese Medicine.
    Wang L; Peng F; Peng C; Du JR
    Am J Chin Med; 2021; 49(3):609-626. PubMed ID: 33683187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal organoids: a model to study the role of microbiota in the colonic tumor microenvironment.
    Nalluri H; Subramanian S; Staley C
    Future Microbiol; 2020 Oct; 15():1583-1594. PubMed ID: 33215543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing the cancer-associated microbiome with small RNA sequencing data.
    Lee WH; Chen KP; Wang K; Huang HC; Juan HF
    Biochem Biophys Res Commun; 2020 Feb; 522(3):776-782. PubMed ID: 31791588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota and mTOR signaling: Insight on a new pathophysiological interaction.
    Noureldein MH; Eid AA
    Microb Pathog; 2018 May; 118():98-104. PubMed ID: 29548696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crypt- and Mucosa-Associated Core Microbiotas in Humans and Their Alteration in Colon Cancer Patients.
    Saffarian A; Mulet C; Regnault B; Amiot A; Tran-Van-Nhieu J; Ravel J; Sobhani I; Sansonetti PJ; Pédron T
    mBio; 2019 Jul; 10(4):. PubMed ID: 31311881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.